Eagle Pharmaceuticals (EGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,354 | 21,897 | 55,321 | 15,384 | 36,562 |
| Receivables | 115,140 | 114,953 | 72,439 | 96,932 | 85,920 |
| Inventories | 42,482 | 44,140 | 47,794 | 63,855 | 57,712 |
| TOTAL | $187,250 | $192,491 | $188,754 | $185,046 | $194,456 |
| Non-Current Assets | |||||
| PPE Net | 1,013 | 1,116 | 1,168 | 1,297 | 1,459 |
| Intangibles | 152,439 | 157,908 | 163,360 | 150,579 | 155,531 |
| Other Non-Current Assets | 64,120 | 62,660 | 52,878 | 49,527 | 30,310 |
| TOTAL | $217,572 | $221,684 | $217,406 | $201,403 | $187,300 |
| Total Assets | $404,822 | $414,175 | $406,160 | $386,449 | $381,756 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,297 | 7,500 | 6,250 | 34,961 | 21,843 |
| Accounts payable and accrued liabilities | 15,843 | 17,108 | 18,993 | 13,215 | 19,971 |
| Accrued Expenses | 62,490 | 73,201 | 85,844 | 73,652 | 67,150 |
| TOTAL | $86,630 | $97,809 | $111,087 | $121,828 | $108,964 |
| Non-Current Liabilities | |||||
| Long Term Debt | 61,896 | 68,829 | 56,216 | 26,431 | 28,018 |
| Other Non-Current Liabilities | 4,256 | 4,692 | 5,297 | 1,874 | 2,256 |
| TOTAL | $66,152 | $73,521 | $61,513 | $32,841 | $34,810 |
| Total Liabilities | $152,782 | $171,330 | $172,600 | $154,669 | $143,774 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,987 | 13,091 | 13,084 | 13,016 | 13,285 |
| Common Shares | 18 | 18 | 18 | 18 | 18 |
| Retained earnings | 122,418 | 117,254 | 111,504 | 103,339 | 110,470 |
| Other shareholders' equity | -1,227 | -1,227 | -1,227 | 9,262 | 2,117 |
| TOTAL | $252,040 | $242,845 | $233,560 | $231,780 | $237,982 |
| Total Liabilities And Equity | $404,822 | $414,175 | $406,160 | $386,449 | $381,756 |